S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 83.1 TWD 0.48%
Market Cap: 9.9B TWD

SCI Pharmtech Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Other Long-Term Assets
NT$233.9m
CAGR 3-Years
-23%
CAGR 5-Years
24%
CAGR 10-Years
14%
Y
YungShin Global Holding Corp
TWSE:3705
Other Long-Term Assets
NT$378.3m
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
7%
Formosa Laboratories Inc
TWSE:4746
Other Long-Term Assets
NT$98.3m
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
6%
ScinoPharm Taiwan Ltd
TWSE:1789
Other Long-Term Assets
NT$640m
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
3%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Other Long-Term Assets
NT$655.2m
CAGR 3-Years
10%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Standard Chem & Pharm Co Ltd
TWSE:1720
Other Long-Term Assets
NT$209m
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
1%

SCI Pharmtech Inc
Glance View

Market Cap
9.9B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
58.86 TWD
Overvaluation 29%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Other Long-Term Assets?
Other Long-Term Assets
233.9m TWD

Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Other Long-Term Assets amounts to 233.9m TWD.

What is SCI Pharmtech Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
14%

Over the last year, the Other Long-Term Assets growth was -25%. The average annual Other Long-Term Assets growth rates for SCI Pharmtech Inc have been -23% over the past three years , 24% over the past five years , and 14% over the past ten years .

Back to Top